50 related articles for article (PubMed ID: 19235753)
21. Expression of sodium-iodide symporter and TSH receptor in subclinical metastatic lymph nodes of papillary thyroid microcarcinoma.
So YK; Son YI; Baek CH; Jeong HS; Chung MK; Ko YH
Ann Surg Oncol; 2012 Mar; 19(3):990-5. PubMed ID: 21879263
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical analysis of sodium iodide symporter expression in metastatic differentiated thyroid cancer: correlation with radioiodine uptake.
Castro MR; Bergert ER; Goellner JR; Hay ID; Morris JC
J Clin Endocrinol Metab; 2001 Nov; 86(11):5627-32. PubMed ID: 11701745
[TBL] [Abstract][Full Text] [Related]
23. Increased expression of the sodium/iodide symporter in papillary thyroid carcinomas.
Saito T; Endo T; Kawaguchi A; Ikeda M; Katoh R; Kawaoi A; Muramatsu A; Onaya T
J Clin Invest; 1998 Apr; 101(7):1296-300. PubMed ID: 9525971
[TBL] [Abstract][Full Text] [Related]
24. Expression of glucose transporter-1, hexokinase-II, proliferating cell nuclear antigen and survival of patients with pancreatic cancer.
Lyshchik A; Higashi T; Hara T; Nakamoto Y; Fujimoto K; Doi R; Imamura M; Saga T; Togashi K
Cancer Invest; 2007; 25(3):154-62. PubMed ID: 17530485
[TBL] [Abstract][Full Text] [Related]
25. Effect of all-trans retinoic acid on sodium/iodide symporter expression, radioiodine uptake and gene expression profiles in a human anaplastic thyroid carcinoma cell line.
Jeong H; Kim YR; Kim KN; Choe JG; Chung JK; Kim MK
Nucl Med Biol; 2006 Oct; 33(7):875-82. PubMed ID: 17045167
[TBL] [Abstract][Full Text] [Related]
26. Reciprocal immunohistochemical expression of sodium/iodide symporter and hexokinase I in primary thyroid tumors with synchronous cervical metastasis.
Jung YH; Hah JH; Sung MW; Kim KH; Cho SY; Jeon YK
Laryngoscope; 2009 Mar; 119(3):541-8. PubMed ID: 19235753
[TBL] [Abstract][Full Text] [Related]
27. Enhancement of sodium/iodide symporter expression in thyroid and breast cancer.
Kogai T; Taki K; Brent GA
Endocr Relat Cancer; 2006 Sep; 13(3):797-826. PubMed ID: 16954431
[TBL] [Abstract][Full Text] [Related]
28. Regulation of the sodium/iodide symporter by retinoids--a review.
Schmutzler C
Exp Clin Endocrinol Diabetes; 2001; 109(1):41-4. PubMed ID: 11573138
[TBL] [Abstract][Full Text] [Related]
29. Sodium/iodide symporter is expressed in the majority of seminomas and embryonal testicular carcinomas.
Micali S; Maggisano V; Cesinaro A; Celano M; Territo A; Reggiani Bonetti L; Sponziello M; Migaldi M; Navarra M; Bianchi G; Filetti S; Russo D
J Endocrinol; 2013 Feb; 216(2):125-33. PubMed ID: 23117572
[TBL] [Abstract][Full Text] [Related]
30. Sodium iodide symporter: its role in nuclear medicine.
Chung JK
J Nucl Med; 2002 Sep; 43(9):1188-200. PubMed ID: 12215558
[TBL] [Abstract][Full Text] [Related]
31. Unusual tumors of the thyroid gland.
Baloch ZW; LiVolsi VA
Endocrinol Metab Clin North Am; 2008 Jun; 37(2):297-310, vii. PubMed ID: 18502328
[TBL] [Abstract][Full Text] [Related]
32. OCT4 expression on a case of poorly differentiated (insular) carcinoma of the thyroid gland and minireview.
Ruangpratheep C; Lohachittranond C; Poonpracha T; Punyarit P
J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S281-9. PubMed ID: 16858970
[TBL] [Abstract][Full Text] [Related]
33. Metastatic tumors to the oral and maxillofacial region: a retrospective study of 19 cases in West China and review of the Chinese and English literature.
Shen ML; Kang J; Wen YL; Ying WM; Yi J; Hua CG; Tang XF; Wen YM
J Oral Maxillofac Surg; 2009 Apr; 67(4):718-37. PubMed ID: 19304027
[TBL] [Abstract][Full Text] [Related]
34. Molecular nuclear therapies for thyroid carcinoma.
Verburg FA; Brans B; Mottaghy FM
Methods; 2011 Nov; 55(3):230-7. PubMed ID: 21704168
[TBL] [Abstract][Full Text] [Related]
35. Thyroid follicular epithelial cell-derived carcinomas: an overview of the pathology of primary and recurrent disease.
Todd WU; Wenig BM
Otolaryngol Clin North Am; 2008 Dec; 41(6):1079-94, vii-viii. PubMed ID: 19040970
[TBL] [Abstract][Full Text] [Related]
36. Thyroid hormone biosynthesis - the importance of the sodium/iodide symporter (NIS).
Kraiem Z
Pediatr Endocrinol Rev; 2003 Dec; 1 Suppl 2():153-4; discussion 154. PubMed ID: 16444152
[No Abstract] [Full Text] [Related]
37. Sodium iodide symporter and the radioiodine treatment of thyroid carcinoma.
Chung JK; Youn HW; Kang JH; Lee HY; Kang KW
Nucl Med Mol Imaging; 2010 Apr; 44(1):4-14. PubMed ID: 24899932
[TBL] [Abstract][Full Text] [Related]
38. [Immunohistochemistry of thyroid cancers. II. Medullary carcinomas (CMT) and "mixed" or "intermediate" tumors].
De Micco C
Ann Pathol; 1990; 10(5-6):297-312. PubMed ID: 1964783
[No Abstract] [Full Text] [Related]
39. Theranostics in Thyroid Cancer.
Eilsberger F; Pfestroff A
PET Clin; 2021 Jul; 16(3):375-382. PubMed ID: 34053581
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
